Related Experiment Video
Updated: May 3, 2026
06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
16.3K
Immune modulation in humans: implications for type 1 diabetes mellitus
Bart O Roep1, Timothy I M Tree2
1Leiden University Medical Center, Department of Immunohaematology & Blood Transfusion, P. O. Box 9600, NL-2300 RC Leiden, Netherlands.
Nature Reviews. Endocrinology
|January 29, 2014
Summary
Type 1 diabetes mellitus (T1DM) results from autoimmune destruction of pancreatic beta cells. Understanding immune regulation in T1DM may lead to targeted therapies for restoring immune balance.
Area of Science:
- Immunology
- Endocrinology
- Genetics
Background:
- Type 1 diabetes mellitus (T1DM) involves autoimmune destruction of pancreatic beta cells in genetically susceptible individuals.
- Impaired immune regulation is a key factor, potentially linked to specific genetic variants affecting immune modulation.
- Despite identified immune defects, some T1DM patients exhibit immune regulation similar to healthy individuals, highlighting complexity.
Purpose of the Study:
- To review current knowledge on immune regulation and dysfunction in T1DM.
- To explore the basis of tissue-specific immune regulation as an alternative to generalized immunosuppression.
Main Methods:
- Review of existing literature on T1DM pathogenesis and immune system interactions.
- Analysis of genetic predispositions and their impact on immune regulation in T1DM.
- Discussion of human studies investigating immune dysregulation in pancreatic islet autoimmunity.
Main Results:
- Genetic variants contribute to impaired immune regulation in T1DM.
- Immune dysregulation in T1DM is complex, with varying capacities among patients.
- Tissue-specific immune regulation offers a potential therapeutic avenue.
Conclusions:
- Understanding the nuances of immune regulation in T1DM is crucial for developing effective treatments.
- Targeting specific immune pathways, rather than broad suppression, may restore immune balance in T1DM.
- Further research into islet autoimmunity regulation can guide novel therapeutic strategies.
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
75
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
01:12Type I Diabetes I: Introduction
45
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
01:22Diabetes Mellitus: Overview and Type I Subtype
5.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
01:26Type II Diabetes I: Introduction
17
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
01:24Type II Diabetes II: Pathophysiology
28
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
01:19Type I Diabetes III: Clinical Manifestations
26
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26